Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P1DI
|
|||
Drug Name |
MCLA-128
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 2 | [1] | |
Company |
MerusUtrecht, Netherlands
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.